Saskatchewan Expands Cystic Fibrosis Drug Coverage
This is a Saskatchewan news story, published by Global News, that relates primarily to Trikafta news.
Saskatchewan news
For more Saskatchewan news, you can click here:
more Saskatchewan newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsGlobal News news
For more news from Global News, you can click here:
more news from Global NewsAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Canadian Cystic Fibrosis registry. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest drug Trikafta news, Cystic fibrosis news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
cystic fibrosis patientsGlobal News
•Saskatchewan expands Trikafta coverage for cystic fibrosis | Globalnews.ca
57% Informative
The provincial government announced it was expanding coverage for the drug Trikafta to include patients with 152 rare genetic mutations.
This change will extend eligibility to the majority of cystic fibrosis patients in Saskatchewan .
The Canadian Cystic Fibrosis registry reports there are over 130 patients affected by the disease in Saskatchewan and nearly 4,500 across Canada .
VR Score
45
Informative language
37
Neutral language
63
Article tone
informal
Language
English
Language complexity
42
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links